Human Monocytes - CD14, CD16 - Ziegler-Heitbrock




Circulating blood monocytes belong to the first line of defense against pathogens and inflammation. Monocytes can be divided into three populations defined by the expression of the cell surface molecules, CD 14 and CD 16. The CD 14++ CD 16− cells, called “classical” monocytes, represent 85% to 95% of the total monocytes in a healthy person whereas CD14− CD 16+, called “proinflammatory” monocytes, are found in greater numbers in the blood of patients with acute inflammation and infectious diseases. This increase in the concentration of proinflammatory monocytes can be a good indicator of an infectious state. This study presents an immunosensor based on impedance detection for specific cell trapping of classical and proinflammatory monocytes. The grafting of specific antibodies (CD14 or CD16) was based on the use of mixed SAM associated with protein G. Each step of the functionalization was characterized by electrochemical methods, quartz crystal microbalance and atomic force microscopy. Faradaic electrochemical impedance spectroscopy and voltametric analysis confirmed the success of the modification process with a surface coverage reaching 92% for the antibody layer. The increase in the deposited mass at each step of the modification process confirmed this results revealing that one protein G in two was bound to an antibody. The cell trapping capacity, evaluated by the variation in the film resistance using non-faradaic impedance spectroscopy revealed that the cell trapping is selective, depending on the specific antibody grafted and quantitative with the range of detection being 1000 to 30000 infected cells. This range of detection is consistent with the application targeted.

Authors: Montrosea A, Cargouc S, Nepveua F, Manczaka R, Guec A-M , Reybier K
Journal: Elsevier
Year: 2013
PubMed: Find in PubMed